1,776 results on '"scleroderma, diffuse"'
Search Results
2. Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer
3. Phase 2 Safety and Efficacy Study of Tulisokibart (MK-7240/PRA023) in Subjects With Systemic Sclerosis Associated With Interstitial Lung Disease (SSc-ILD) (MK-7240-007) (ATHENA-SSc-ILD)
4. A Clinical Study to Evaluate Ianalumab in Participants With Diffuse Cutaneous Systemic Sclerosis
5. Determine Effectiveness of Anifrolumab In SYstemic Sclerosis (DAISY) (DAISY)
6. Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Diffuse Cutaneous Systemic Sclerosis
7. A Study of KHK4827 in Patients With Systemic Sclerosis
8. Cardiac Assessment by PV Loop in IPAH and Scleroderma PAH (CALIPSO)
9. A Phase 3 Study of KHK4827 in Patients With Systemic Sclerosis
10. A Study of CC-97540, CD-19-Targeted Nex-T CAR T Cells, in Participants With Severe, Refractory Autoimmune Diseases
11. Evaluating Tools to Communicate Scleroderma Research Results to Patients (SPIN-KT)
12. RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
13. Home Based Clinical Management of Interstitial Lung Disease in Systemic Rheumatic Diseases (RMD-mILDer)
14. DR-0201 in Subjects With Autoimmune Diseases
15. A Study Evaluating the Efficacy and Safety of Vixarelimab in Participants With Idiopathic Pulmonary Fibrosis and in Participants With Systemic Sclerosis-Associated Interstitial Lung Disease
16. Collection of Airway, Blood and/or Urine Specimens From Subjects for Research Studies
17. UVA-1 for Treatment of Skin Tightening and Improvement of Hand Function in Scleroderma
18. Patient Reported Outcomes with UVA-1 Therapy for Treatment of Sclerosing Skin Diseases
19. A Study of CNTY-101 in Participants With Refractory B Cell-mediated Autoimmune Diseases (CALiPSO-1) (CALiPSO-1)
20. NKX019, Intravenous Allogeneic Chimeric Antigen Receptor Natural Killer Cells (CAR NK), in Participants With Immune-Mediated Diseases (Ntrust-2)
21. Efficacy and Safety of Riociguat in Incipient Pulmonary Vascular Disease as an Indicator for Early PAH (ESRA)
22. A Study to Evaluate VIB7734 in Participants With Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythematosus (CLE), Sjogren's Syndrome, Systemic Sclerosis, Polymyositis, and Dermatomyositis
23. Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders
24. A Study to Assess the Efficacy and Safety of Efgartigimod PH20 SC in Adults with Systemic Sclerosis (eSScape)
25. A Study of Guselkumab in Participants With Systemic Sclerosis
26. An Open-label Extension Trial of HZNP-HZN-825-301 in Adult Participants With Diffuse Cutaneous Systemic Sclerosis (Diffuse Cutaneous SSc)
27. Phase I/II Randomized Clinical Trial of Allogeneic Adipose Tissue-derived Mesenchymal Stromal Cells Systemic Infusion in Severe Systemic Sclerosis (MSC-AT-SSc)
28. Impact of Transcutaneous Auricular Vagus Nerve Stimulation on Digestive Symptoms in Systemic Sclerosis Systemic Sclerosis (AVADIS)
29. Upfront Autologous HSCT Versus Immunosuppression in Early Diffuse Cutaneous Systemic Sclerosis (UPSIDE)
30. Phenotyping of Chronic Pain in Diffused Systemic Scleroderma (PAIN SSc)
31. A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease (BLISSc-ILD)
32. PET Imaging of Systemic Sclerosis Using FDG and 68Ga-DOTA-Siglec-9 (SYSPET)
33. A Study to Investigate the Long-term Safety and Efficacy of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
34. An Open-label, Phase 2 Study to Assess the Efficacy and Safety of Nemolizumab in Subjects With Systemic Sclerosis
35. US Zamto-cel Autoimmune Diseases
36. Extracorporeal Photopheresis in Early Diffuse Cutaneous Systemic Sclerosis
37. Development and Evaluation of an Evidence-based Education Program for People With Hand Dysfunction in Scleroderma
38. Post-marketing Surveillance on Long Term Use of Ofev Capsules in Systemic Scleroderma Associated Interstitial Lung Disease (SSc-ILD) in Japan
39. Platform Clinical Study for Conquering Scleroderma (CONQUEST)
40. Hand Disability in Systemic Sclerosis - Digital Ulcers
41. Study of the Efficacy of Nintedanib+Tocilizumab in Patients With Systemic Sclerosis and Interstitial Lung Disease (NINTOC-TU)
42. Scleroderma Registry & Repository At the Hospital for Special Surgery
43. Safety and Tolerability Study of AVID200 in Pts With Diffuse Cutaneous Systemic Sclerosis
44. Open Label Extension Study of Brentuximab Vedotin in Early dcSSc
45. Clinical Study of Divozilimab in Patients With Systemic Scleroderma (LIBERIUS)
46. Identifying Unique Pathogenic Macrophages in Systemic Sclerosis-ILD
47. Anti-CD19 CAR T-Cell Therapy in Refractory Systemic Autoimmune Diseases (CATARSIS)
48. Respiratory Muscle Training in Scleroderma
49. Ultrasonic COmparison of Salivary Glands in Autoimmune Diseases (COUGAR) (COUGAR)
50. Preventive Effect of Clopidogrel on the Systemic Sclerosis Development Risk (PSSIT)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.